(RTTNews) - Viking Therapeutics, Inc. (VKTX), Wednesday announced positive data from Phase 1b study of VK0214 in patients with X-linked adrenoleukodystrophy (X-ALD). X-ALD is a rare and often fatal ...

Novel, Selective Thyroid Receptor Beta Agonist Being Evaluated in X-ALD Patients Following Successful Completion of Phase 1 Healthy Volunteer Study SAN DIEGO, June 24, 2021 /PRNewswire/ -- Viking ...

THE GROUND BY SUNDAY AFTERNOON. ALL RIGHT. THANK YOU OLGA. ALDI IS A RARE GENETIC DISEASE THAT AFFECTS 1 IN 17,000 PEOPLE WORLDWIDE. THE DIAGNOSIS HIT ONE FAMILY WHO IS ORIGINALLY FROM ALBUQUERQUE.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--NeuroVia, Inc., a biopharmaceutical company focused on developing innovative therapies for rare genetic neurological diseases, announced the closing of a Series A ...

I remember watching the 1992 film “Lorenzo’s Oil” in middle school science class. Based on a true story, the film is about a boy named Lorenzo Odone. He is diagnosed with a rare disease called ...

CHICAGO – Treatment of boys with X-linked adrenoleukodystrophy (ALD) with Lorenzo's oil (LO) reduced their risk of developing the severe debilitating form of the disease, according to a study in the ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...